453
Views
11
CrossRef citations to date
0
Altmetric
Review Article

Signaling pathways in anchoring junctions of epithelial cells: cell-to-cell and cell-to-extracellular matrix interactions

, &
Pages 67-75 | Received 03 Apr 2014, Accepted 02 Jun 2014, Published online: 14 Jul 2014

References

  • González-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008;1778:729–56
  • Ross MH, Kaye GI, Pawlina W. Histology: a text and atlas. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2003
  • Mescher A. Junqueiras’s basic histology: text and atlas. 12th ed. New York: McGraw Hill Medical; 2009
  • Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003;4:225–36
  • Braga V. Cell–cell adhesion and signalling. Curr Opin Cell Biol 2002;14:546–56
  • Alberts B, Johnson A, Lewis J, et al. Cell junctions. Molecular biology of the cell. 4th ed. New York: Garland Science; 2002
  • Balda M. Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol 2003;13:310–18
  • Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol 1963;17:375–412
  • Green KJ, Getsios S, Troyanovsky S, Godsel LM. Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol 2010;2:a000125
  • Tsukita S, Furuse M, Itoh M. Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol 1999;11:628–33
  • Tian X, Liu Z, Niu B, Zhang J, et al. E-cadherin/β-catenin complex and the epithelial barrier. J Biomed Biotechnol 2011;2011:567305
  • Delva E, Tucker DK, Kowalczyk AP. The desmosome. Cold Spring Harb Perspect Biol 2009;1:a002543
  • Nielsen MS, Axelsen LN, Sorgen PL, et al. Gap junctions. Compr Physiol 2012;2:1981–2035
  • Petit V, Thiery JP. Focal adhesions: structure and dynamics. Biol Cell 2000;92:477–94
  • Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 1999;112:411–18
  • Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 2007;127:2525–32
  • Kurita S, Yamada T, Rikitsu E, et al. Binding between the junctional proteins afadin and PLEKHA7 and implication in the formation of adherens junction in epithelial cells. J Biol Chem 2013;288:29356–68
  • Jamora C, Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 2002;4:E101–8
  • van Roy F. Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat Rev Cancer. 2014;14:121–34
  • Barth AIM, Nathke IS, Nelson WJ. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 1997;9:683–90
  • Yap AS, Kovacs EM. Direct cadherin-activated cell signaling: a view from the plasma membrane. J Cell Biol 2003;160:11–16
  • Conacci-sorrell M, Zhurinsky J, Ben-Ze’ev A. The cadherin–catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987–91
  • Dufour S, Mège R-M, Thiery JP. α-Catenin, vinculin, and F-actin in strengthening E-cadherin cell–cell adhesions and mechanosensing. Cell Adh Migr 2013;7:345–50
  • Desai R, Sarpal R, Ishiyama N, et al. Monomeric α-catenin links cadherin to the actin cytoskeleton. Nat Cell Biol 2013;15:261–73
  • Meng W, Takeichi M. Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol 2009;1:a002899
  • Anastasiadis PZ, Reynolds AB. The p120 catenin family: complex roles in adhesion, signaling and cancer. J Cell Sci 2000;113:15–30
  • Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev. 1999;18:15–30
  • Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis 2008;4:68–75
  • MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009;17:9–26
  • Wang J, Wynshaw-Boris A. The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/differentiation. Curr Opin Genet Dev 2004;14:533–9
  • Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J 2012;31:2714–36
  • Khramtsov AI, Khramtsova GF, Tretiakova M, et al. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol 2010;176:2911–20
  • Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469–80
  • Maretzky T, Reiss K, Ludwig A, et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA 2005;102:9182–7
  • Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2010;2:1–24
  • Gomperts BD, Kramer IM, Tatham PER. Signal Transduction. 2nd ed. Boston Elsevier/Academic Press; 2009:315–43
  • Kohn AD, Moon RT. Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 2005;38:439–46
  • Comoglio PM, Boccaccio C, Trusolino L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol 2003;15:565–71
  • Hoschuetzky H, Aberle H, Kemler R. Beta-catenin mediates the interaction of the cadherin–catenin complex with epidermal growth factor receptor. J Cell Biol 1994;127:1375–80
  • Hazan RB, Norton L. The epidermal growth factor receptor modulates the interaction of e-cadherin with the actin cytoskeleton. Cell Biol Metab 1998;273:9078–84
  • Fujita Y, Krause G, Scheffner M, et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 2002;4:222–31
  • Gilcrease MZ. Integrin signaling in epithelial cells. Cancer Lett 2007;247:1–25
  • Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol 2011;3:1–14
  • Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci 2006;119:3901–3
  • Hehlgans S, Haase M, Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta 2007;1775:163–80
  • Berridge MJ. Cell signalling biology. Portland: Portland Press Limited; 2012
  • Yamada KM, Even-ram S. Integrin regulation of growth factor receptors. Nat Cell Biol 2002;4:E75–6
  • Moro L, Dolce L, Cabodi S, et al. Integrin-induced epidermal growth factor receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J Biol Chem 2002;277:9405–14
  • Araya J, Cambier S, Morris A, et al. Integrin-mediated transforming growth factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit. Am J Pathol 2006;169:405–15
  • Yu X, Miyamoto S, Mekada E. Integrin alpha 2 beta 1-dependent EGF receptor activation at cell–cell contact sites. J Cell Sci 2000;113:2139–47
  • Schneller M, Vuori K, Ruoslahti E. Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J. 1997;16:5600–7
  • Baron W, Shattil SJ, Ffrench-Constant C. The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alphabeta3 integrins. EMBO J 2002;21:1957–66
  • Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285:1028–33
  • De Rooij J, Kerstens A, Danuser G, et al. Integrin-dependent actomyosin contraction regulates epithelial cell scattering. J Cell Biol 2005;171:153–64
  • Avizienyte E, Wyke AW, Jones RJ, et al. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 2002;4:632–8
  • Chen X, Gumbiner BM. Crosstalk between different adhesion molecules. Curr Opin Cell Biol 2006;18:572–8
  • Koenig A, Mueller C, Hasel C, et al. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res 2006;66:4662–71
  • Avizienyte E, Fincham VJ, Brunton VG, Frame MC. Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition. Mol Biol Cell 2004;15:2794–803
  • Avizienyte E, Frame MC. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 2005;17:542–7
  • Yano H, Mazaki Y, Kurokawa K, et al. Roles played by a subset of integrin signaling molecules in cadherin-based cell–cell adhesion. J Cell Biol 2004;166:283–95
  • Hintermann E, Yang N, O’Sullivan D, et al. Integrin alpha6beta4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell junctions in keratinocytes. J Biol Chem 2005;280:8004–15
  • Chartier NT, Lainé M, Gout S, et al. Laminin-5-integrin interaction signals through PI 3-kinase and Rac1b to promote assembly of adherens junctions in HT-29 cells. J Cell Sci 2006;119:31–46
  • Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev 2007;17:45–51
  • Reed KR, Athineos D, Meniel VS, et al. B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver. Proc Natl Acad Sci USA 2008;105:18919–23
  • Fuchs E. The tortoise and the hair: slow-cycling cells in the stem cell race. Cell 2009;137:811–19
  • Morris EJ, Ji J-Y, Yang F, et al. E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 2008;455:552–6
  • Firestein R, Bass AJ, Kim SY, et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008;455:547–51
  • Chen B, Dodge ME, Tang W, et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 2009;5:100–7
  • Guarino M, Tosoni A, Nebuloni M. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum Pathol 2009;40:1365–76
  • Patel SR, Jenkins J, Papadopolous N, et al. Pilot study of vitaxin – an angiogenesis inhibitor-in patients with advanced leiomyosarcomas. Cancer 2001;92:1347–8
  • Park CC, Zhang H, Pallavicini M, et al. β1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res 2006;66:1526–35

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.